Study Evaluating InductOs in Diaphyseal Tibia Fractures

Phase 4 Completed 277 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

RandomizedSingle-groupSingle-blindTreatment

Summary

Demonstrate a larger proportion of subjects with healed fractures among subjects treated with InductOs and reamed, locked intramedullary nailing compared to subjects treated with reamed, locked intramedullary nailing alone.

Timeline

Start: 2003-09
Primary completion: 2008-07
Completion: 2008-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	rhBMP-2	Protein / enzyme biologic	1.5 mg/ml	Other

Indications

No indication recorded.